Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples

Mohammed T. Al-Samri; Andrea Benedetti; David Préfontaine; Ron Olivenstein; Catherine Lemière; Parameswaran Nair; James G. Martin; Qutayba Hamid

doi:10.1016/j.jaci.2010.02.005

Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples

Mohammed T. Al-Samri, Andrea Benedetti, David Préfontaine, Ron Olivenstein, Catherine Lemière, Parameswaran Nair, James G. Martin, Qutayba Hamid

Department of Pediatrics

Research output: Contribution to journal › Letter › peer-review

59 Citations (Scopus)

Original language	English
Pages (from-to)	1161-1163.e4
Journal	Journal of Allergy and Clinical Immunology
Volume	125
Issue number	5
DOIs	https://doi.org/10.1016/j.jaci.2010.02.005
Publication status	Published - May 2010

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2010.02.005

Cite this

Al-Samri, M. T., Benedetti, A., Préfontaine, D., Olivenstein, R., Lemière, C., Nair, P., Martin, J. G., & Hamid, Q. (2010). Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples. Journal of Allergy and Clinical Immunology, 125(5), 1161-1163.e4. https://doi.org/10.1016/j.jaci.2010.02.005

Al-Samri, MT, Benedetti, A, Préfontaine, D, Olivenstein, R, Lemière, C, Nair, P, Martin, JG & Hamid, Q 2010, 'Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples', Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1161-1163.e4. https://doi.org/10.1016/j.jaci.2010.02.005

@article{fccc3ff9b22746ab940e9e16937f4cf7,

title = "Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples",

author = "Al-Samri, {Mohammed T.} and Andrea Benedetti and David Pr{\'e}fontaine and Ron Olivenstein and Catherine Lemi{\`e}re and Parameswaran Nair and Martin, {James G.} and Qutayba Hamid",

note = "Funding Information: Disclosure of potential conflict of interest: R. Olivenstein is on the advisory boards for GlaxoSmithKline and AstraZeneca, receives lecture fees from Boehringer-Ingelheim , and receives research support from MedImmune and Novartis . C. Lemi{\`e}re receives research support from the Centers for Disease Control and Prevention and the Quebec Occupational Health and Safety Research Institute (IRSST) and participates on advisory committees for GlaxoSmithKline and AstraZeneca. P. Nair receives research support from Schering-Plough and Ception, Inc . The rest of the authors have declared that they have no conflict of interest. Funding Information: This study and the Difficult Asthma Program are supported by the Richard and Edith Strauss Canada Foundation . The Meakins-Christie Laboratories and McGill University Health Centre Research Institute are supported in part by a Center grant from Le Fonds de la Recherche en Sant{\'e} du Qu{\'e}bec and the J.T. Costello Memorial Research Fund . ",

year = "2010",

month = may,

doi = "10.1016/j.jaci.2010.02.005",

language = "English",

volume = "125",

pages = "1161--1163.e4",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy

T2 - A prospective study using multiple samples

AU - Al-Samri, Mohammed T.

AU - Benedetti, Andrea

AU - Préfontaine, David

AU - Olivenstein, Ron

AU - Lemière, Catherine

AU - Nair, Parameswaran

AU - Martin, James G.

AU - Hamid, Qutayba

N1 - Funding Information: Disclosure of potential conflict of interest: R. Olivenstein is on the advisory boards for GlaxoSmithKline and AstraZeneca, receives lecture fees from Boehringer-Ingelheim , and receives research support from MedImmune and Novartis . C. Lemière receives research support from the Centers for Disease Control and Prevention and the Quebec Occupational Health and Safety Research Institute (IRSST) and participates on advisory committees for GlaxoSmithKline and AstraZeneca. P. Nair receives research support from Schering-Plough and Ception, Inc . The rest of the authors have declared that they have no conflict of interest. Funding Information: This study and the Difficult Asthma Program are supported by the Richard and Edith Strauss Canada Foundation . The Meakins-Christie Laboratories and McGill University Health Centre Research Institute are supported in part by a Center grant from Le Fonds de la Recherche en Santé du Québec and the J.T. Costello Memorial Research Fund .

PY - 2010/5

Y1 - 2010/5

UR - http://www.scopus.com/inward/record.url?scp=77951666051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951666051&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2010.02.005

DO - 10.1016/j.jaci.2010.02.005

M3 - Letter

C2 - 20392486

AN - SCOPUS:77951666051

SN - 0091-6749

VL - 125

SP - 1161-1163.e4

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -

Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this